Rho proteins are a branch of GTPases that belongs to the Ras superfamily which are critical elements of signal transduction pathways leading to a variety of cellular responses. This family of small GTPases has been involved in diverse biological functions such as cytoskeleton organization, cell growth and transformation, cell motility, migration, metastasis, and responses to stress. We report that several human Rho proteins including Rho A, Rho C and Rac 1, are capable of inducing apoptosis in dierent cell systems like murine NIH3T3 ®broblasts and the human erythroleukemia K562 cell line. Since K562 cells are devoid of p53, apoptosis induced by Rho in this system is independent of p53. Rho-dependent apoptosis is mediated by the generation of ceramides, and it is drastically inhibited by ectopic expression of Bcl2, both under in vitro and in vivo conditions. Furthermore, the human oncogenes vav and ost that have been shown to function as guanine exchange factors for Rho proteins, were also able to induce apoptosis under similar conditions. Finally, we also report that the levels of endogenous Rho proteins are increased when U937 myeloid leukemia cells are exposed to apoptosis-inducing conditions such as TNFa treatment. Furthermore, TNFa-induced apoptosis in these cells is inhibited by expression of a dominant negative mutant of Rac 1 but it is not aected by a similar mutant of Rho A. These results suggest that Rho proteins play an important role in the physiological regulation of the apoptotic response to stress-inducing agents.
Introduction
Apoptosis is a genetically controled response of many types of cells to commit suicide after physiological stimuli in a number of conditions including normal development, immune response and disease (Arends and Wyllie, 1991; Arends and Harrison, 1994; Harrington et al., 1994b) . It is a highly regulated process characterized by speci®c morphological changes in the dying cell including cell shrinkage, chromatin condensation and cellular fragmentation into membrane-bound bodies. A common biochemical marker of apoptosis is the degradation of nuclear DNA resulting in a ladder of nucleosome-sized DNA fragments. A still ill-de®ned cascade of events takes place in the cytoplasm of a dying cell after the cell is commited to apoptosis. In this cascade, dierent kinds of molecules may be involved such as protein kinases, proteases and a nuclease, as well as some second messengers such as internal pH, Ca 2+ release and ceramides production (Arends and Wyllie, 1991; Arends and Harrison, 1994; Harrington et al., 1994b; Hannun, 1994) .
It has become clear that some oncogenes and oncosuppressor genes can dually in¯uence the probability of cell death as well as that of cell replication and proliferation. Thus, it has been shown recently that some dominant oncogenes exhibit the ability to trigger apoptosis. The transcription factor c-Myc is oncogenic when its expression is dysregulated, and a potent inducer of apoptosis after serum withdrawal (Evan et al., 1992; Arends et al., 1993) . The cellular decision between these two responses is determined by other signals, such as the presence of growth factors or other survival stimuli (Harrington et al., 1994b) . Recently, it has been reported that speci®c activation of the Raf kinase pathway by Ras mutants, enhances the c-Myc-induced apoptosis, while activation of Rasmediated phosphatidylinositol 3-kinase (PI3K) inhibits this eect (Kaumann-Zeh et al., 1997) . R-ras, a member of the Ras superfamily of GTPases, is another gene that can be either oncogenic (SaÂ ez et al., 1994) or promote apoptosis in the absence of growth factors (Wang et al., 1995) . Yet, another transcription factor, c-Fos, has been implicated as a key molecule in cell proliferation and transformation and it is associated with apoptotic cell death induced by antiproliferative conditions (Preston et al., 1996) . Finally, several virus encoded proteins such as E1A, are potent inducers of apoptosis in dierent cell systems (Harrington et al., 1994a,b) .
Rho proteins belong to the Ras superfamily of small GTPases and can be divided into several subclasses comprising Rho, Rac, Cdc42 and TC10 proteins. The rho gene was ®rst identi®ed in Aplysia californica (Madaule and Axel, 1985) , and subsequently in humans (Chardin et al., 1988) . The Aplysia Rho protein is highly homologous to its mammalian counterparts Rho A, Rho B and Rho C. Within this family there are also included Rho G, Rho E, Rac 1, Rac 2, CDC42Hs and TC10 proteins (Maudale and Axel, 1985; Chardin et al., 1988; Didsbury et al., 1989; Shinjo et al., 1990; Vincent et al., 1992) . Rho proteins function as a molecular switch that modulates the activation of several enzymes involved in dierent biological processes such as cell morphology and motility, smooth muscle contraction and platelet aggregation (Takai et al., 1995) .
We have previously reported that NIH3T3 cells overexpressing the Aplysia californica rho gene are tumorigenic when injected into nude mice (Perona et al., 1993) . Furthermore, overexpression of this gene in NIH3T3 cells induces apoptosis after serum deprivation (JimeÂ nez et al., 1995) . This eect is related to the generation of ceramides , a putative second messenger for apoptosis (Hannun and Obeid, 1995; Jarvis et al., 1994; Obeid et al., 1993; Testi, 1996) . Moreover, the apoptotic index in tumors generated by rho-transformed NIH3T3 cells is similar to those induced by E1A-transformed cells (JimeÂ nez et al., 1995) a demonstration that Rho induces apoptosis under in vivo conditions. Consistent with a dual role of Rho proteins in cell growth and apoptosis, it has been demonstrated that ectopic expression of the human Rho A , Rho B and Rac 1 (Qiu et al., 1995) in murine cells induce tumorigenicity when the cells are inoculated into nude mice. UV light and other damaging agents increase expression of Rho B in NIH3T3 cells very rapidly, by transcriptional activation of the gene, as occurs with other proto-oncogenes like c-Fos and c-Jun (Fritz et al., 1995) . Moreover, Rho A expression is increased also after treatment with lovastatin, a drug that induces growth arrest of human breast cancer cells (Moscow et al., 1994) . In contrast with these results, Rho B is also expressed transiently after stimulation by growth factors and oncogenes with Tyr-kinase activity such as v-src and v-fms (Jahner and Hunter, 1991) , and Ras-induced transformation requires Rho proteins as downstream elements Lebowitz et al., 1995; Qiu et al., 1995) .
Since there is abundant evidence implicating human Rho proteins in cell growth and transformation, but only circumstancial evidence that human Rho proteins are involved in apoptosis, we have investigated further the possible role of the human rho gene family in apoptosis. We stably overexpressed the Rho A, Rho C and Rac 1 wild type proteins and some of the oncogenic versions in NIH3T3 cells, as well as two of their known exchange factors, the human ost and vav oncogenes (Horii et al., 1994; Crespo et al., 1996) . We demonstrate here that human Rho proteins participate in the induction of apoptosis by serum deprivation or some physiological stimuli such as TNFa. Our results strongly support the hypothesis of a role for the human Rho proteins in the regulation of apoptosis.
Results

Human Rho proteins induce apoptotic cell death in NIH3T3 cells
We have previously shown that overexpression of the rho gene from Aplysia californica in NIH3T3 cells is able to induce apoptosis after serum deprivation (JimeÂ nez et al., 1995) and that this eect is mediated by the generation of ceramides . Since this eect may be due to signaling con¯icts because of species dierences of the proteins, we investigated if the human versions of the family of rho genes play the same role triggering programmed cell death under similar conditions, using the NIH3T3 ®broblasts cell system. To that end, we stably overexpressed the Rho A and Rac 1 wild type proteins and their oncogenic versions, Rho A-Leu 63 (Rho A QL) and Rac 1-Leu 61 (Rac 1 QL) in NIH3T3 cells. After transfection and selection for neomycin resistance, cells were characterized by Western blot using speci®c antibodies for each protein. Figure 1a shows the levels of expression of these proteins in those cell lines selected for further analysis.
In the absence of serum, the cells overexpressing either Rho A or Rac 1 proteins readily underwent apoptosis, measured by DNA fragmentation and the production of the typical nucleosomal DNA ladder (Figure 1b) . In contrast, the parental cell line transfected with the vector alone and selected for neomycin resistance, showed no apparent apoptosis under similar conditions. This eect, analysed after Figure 1 Induction of apoptosis by overexpression of the human Rho proteins. (a) NIH3T3 cells were transfected with appropriate plasmids carrying the human genes rho A, rho A-Leu63, rac 1 and rac 1-Leu61. Pools of transfected cells were selected for G418 resistance, and equivalent amounts of total protein lysates were analysed by Western blot for the levels of expression of each protein using speci®c antibodies. Control indicates extracts from cells transfected with the vector alone, pCEV29. Rho A indicates wild type pCEV29-RhoA, Rho A QL indicates the constitutively active pCEV29-RhoA Leu63 mutant; Rac 1 indicates wild type pCEV29-Rac1, and Rac 1 QL indicates the constitutively active pCEV29-Rac1 Leu61 mutant. (b) Analysis of apoptosis induction by the DNA fragmentation assay in Rho A and Rac 1 overexpressing cells under serum-deprived conditions. Results shown correspond to pools of NIH3T3 constitutively expressing wild type Rho A or Rac1 proteins and their oncogenic versions, rho A-Leu63 (rhoA QL) and rac 1-Leu61 (rac 1 QL) as well as the vector (pCEV29). Cells were incubated for 24 h in DMEM without serum. Cells were then analysed for DNA fragmentation in agarose gels stained with ethidium bromide. (c) Expression of Rho C protein was achieved by transfection of the pLNCX-rho C plasmid in NIH3T3 cells. After, selection with G418, individual clones were isolated as described in Materials and methods. Equivalent amounts of cell extracts were analysed by Western blot using an antibody that speci®cally recognizes Rho A and C proteins (data not shown). VC1 indicates cells transfected with the pLNCX empty vector and RC1, RC3 and RC5 indicates individual clones from the transfection using the pLNCX-rho C plasmid. The arrow indicates the position of the Rho C protein. (d) Analysis of DNA ladder after 24 h of incubation in DMEM deprived of serum in the indicated cell lines as described in c 24 h of serum deprivation, was observed for both wild type versions of the rho A and rac 1 genes and their oncogenic versions. Some degree of advantage was observed with the wild type over the mutated versions, most likely due to the fact that the mutated versions were more oncogenic than their corresponding wild type counterparts.
Similarly to that observed with Rho A and Rac 1, overexpression of the wild type human Rho C, another member of the Rho family, was also capable of inducing apoptosis in NIH3T3 cells. We transfected the plasmid pLNCX-Rho C and the negative control, the empty pLNCX plasmid, in NIH3T3 cells and after selection by G418 resistance, several clones were isolated and analysed by Northern blot (data not shown) and Western blot ( Figure 1c ). As shown in Figure 1d , in the absence of serum, the typical DNA fragmentation in 180 bp-multiple fragments was clearly visible only in the Rho C-overexpressing cells, and no signi®cant DNA degradation was observed in control cells under identical conditions.
To further con®rm the induction of apoptotic death, we also analysed the status of the cells by¯ow cytometry. Expression of either rho A or rac 1 genes enhanced the rates of apoptosis at 24 h of serum deprivation compared to the control cells, as measured by the appearance of hypodiploid DNA peaks ( Figure  2 ). All the above results clearly demonstrate that overexpression of the human Rho A, Rho C or Rac 1 proteins can induce apoptosis in NIH3T3 cells after serum withdrawal.
Induction of apoptosis by guanine exchange factors for Rho proteins in murine ®broblasts
The activity of Rho proteins is regulated by guanine nucleotide exchange factors which catalyze the transition between the GDP-bound state and the GTPbound state. The ability of promoting the GDP/GTP exchange is mediated by two conserved regions of these molecules, designated as the Dbl-homology (DH) domain and the Pleckstrin-homology (PH) domain (Cerione and Zheng, 1996) . Rho exchange factors have been enclosed in a rapidly growing family known as the Dbl family, which includes the Dbl protein itself, identi®ed in 1985 from a diuse B-cell lymphoma (Eva and Aaronson, 1985) , Ost, isolated from a rat osteosarcoma (Horii et al., 1994) and Vav, cloned as a transforming gene from a human hematopoietic cell line (Katzav et al., 1989) . It has been established by in vitro experiments that Ost has the ability to catalyze GDP/GTP exchange for RhoA and Cdc42Hs. Furthermore, this molecule was able to bind speci®cally to the Rac1-GTP form, suggesting that Ost could also serve as an eector molecule for this GTPase (Horii et al., 1994) . Vav has been reported as able to activate Rho, Rac and CDC42 proteins in vitro (Han et al., 1997) , and as a speci®c exchange factor for Rac 1 in vivo .
We explored whether vav and ost had the same properties as Rho proteins for the induction of programmed cell death under similar conditions. Cells were transfected as indicated under Materials and methods with the appropriate vectors carrying either the vav proto-oncogene, its activated version (vav oncogene), or the ost oncogene, and selected cells for Figure 2 Flow-cytometry analysis of Rho-expressing cells induced to undergo apoptosis by serum deprivation. Equivalent number of cells of each cell line were seeded and grown in DMEM supplemented with 10% NCS for 48 h. After this period, the medium was changed and the cells cultured in DMEM without serum for 24 h. Apoptotic ®gures were only detectable above background levels in cells carrying rhoA-Leu63 (Rho A QL) and rac 1-Leu61 (Rac 1 QL), whereas cells transfected with the empty vector (pCEV29) did not display any clear apoptotic population above background level in the sub G 0 /G 1 region. As a positive control, NIH3T3 cells transfected with a plasmid carrying the E1A gene were used G418 resistance as a pool of clones or mass culture. Analysis of the levels of expression of Vav proteins was carried out by Western blotting (Figure 3a) . Also, the ability of transfected cells to grow in soft agar was analysed ( Figure 3b ). Appropriate cell lines were chosen for further analysis. Induction of apoptosis after serum deprivation was analysed by the appearance of the DNA ladder in the cells constitutively overexpressing these genes. As shown in Figure 3c , transformation by either ost oncogene, or the vav proto-oncogene or the oncogene eciently induced apoptosis under serum deprivation. In contrast, under similar conditions, the typical DNA fragmentation ladder could not be observed in the control cells. Thus, transformation by the human oncogenes vav and ost, coding for guanine exchange factors speci®c for the Rho proteins, does eciently induce apoptosis under serum withdrawal, in keeping with the results obtained with the human Rho and Rac 1 proteins.
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Induction of apoptosis by Rho proteins is independent of p53
There is abundant evidence indicating that apoptosis can be induced by both p53-dependent and p53-independent mechanisms (Harrington et al., 1994b) . Thus, we next investigated if expression of the Rho proteins was able to induce apoptosis in cells devoid of p53. To that end we used the human erythroleukemia cell line, K562. This cell system is known to lack p53 expression and has been used frequently as a model for studies on apoptosis (Bettaieb et al., 1996) . We ®rst generated appropriate cell lines overexpressing the wild type human Rho C protein by transfection of the plasmid pLNCX-Rho C into the K562 cells and selection with G418 of both mass cultures and several individual clones. Expression of the exogenous Rho C protein was analysed by Northern blot (Figure 4a) . One of the mass cultures (Pool) and the selected clones CP3, CP7 and KC5H, expressing high levels of the Rho C-speci®c, pLNCX-driven mRNAs, were selected for further analysis. Levels of expression of the Rho C protein was also determined by Western blotting for the CP3 and CP7 clones and the pool of transfected cells before subcloning (Figure 4b ), using a polyclonal antibody that recognizes both Rho A and Rho C (data not shown). Protein levels correlated with mRNA expression levels in all cases tested, normalized to the respective levels of total protein loaded in the gel determined by Ponceau S staining (data not shown).
Selected cell lines were then tested for the induction of apoptosis after serum deprivation using as negative controls the parental K562 cells and a negative clone, CP5, with no detectable levels of expression of the exogenous Rho C protein. A clear correlation could be observed between expression of Rho C and induction of cell death since cell death could be observed only in those cell lines that expressed signi®cant levels of the Rho C proteins. Cell death was determined by the trypan blue staining method ( Figure 4c ) and apoptosis con®rmed by the anexin staining method (Figure 4d ). In contrast, no cell death was observed in the control cells as well as those that were negative for the expression of the Rho C protein using either method. These results demonstrate that apoptosis induced by Rho proteins is not species speci®c and that it is independent of the presence of p53, at least in the human K562 cell line system.
Apoptosis induction in cells overexpressing human Rho proteins parallels with elevated levels of ceramides production
There are many results indicating that ceramides may be an important element of signaling pathways leading to programmed cell death (Testi, 1996; Hannun and Obeid, 1995) . Ceramide levels are signi®cantly increased in HIVinfected T lymphocytes that undergo apoptosis (Van Veldhoven et al., 1992) and in endothelial cells after ionizing radiation which are also triggered to apoptotic cell death (Haimovitz-Friedman et al., 1994) . Ceramides are also induced by treatment with TNFa or the Fas ligand, two potent mechanisms for induction of apoptosis (Gulbins et al., 1995; Wiegmann et al., 1994) . A more direct support comes from the evidence that direct addition of synthetic ceramides induce apoptosis in myeloid and lymphoid cells (Obeid et al., 1993; Jarvis et al., 1994; Ji et al., 1995) . Although little is known about the precise mechanism for the induction of apoptosis induced by ceramides, it has been shown recently that activation of the JNK/SAPK cascade is required for ceramide-induced apoptosis in leukaemia and endothelial cell lines (Verheij et al., 1996) .
We next investigated whether the expression of the human Rho proteins induced an increase in the levels of ceramides under conditions of induction of apoptosis. As shown in Figure 5 , cells transfected with the activated versions (QL) of the rho A or the rac 1 genes showed a relatively modest increase in the basal levels of ceramides in the presence of serum. Removal of serum and therefore induction of apoptosis, was followed by an increase in ceramide levels of up to ®vefold. Under similar experimental conditions, the control cells showed a much lower increase in ceramide levels that was not associated with the induction of apoptosis within the time frame of the experiment. Thus, there was a speci®c increase in the basal levels of ceramides in the cells expressing either Rho A or Rac 1 proteins relative to the control cells.
We have further investigated whether ceramides could be involved in the induction of apoptosis by Rho proteins. To that end, we investigated if addition of ceramides was sucient to induce apoptosis in the Rho-expressing cells as well as in the parental NIH3T3 cells. Addition of the synthetic, permeable C2 ceramide in the presence of 10% serum for 48 h was sucient to induce DNA fragmentation only in those cells overexpressing Rho A, Rho C or Rac 1 as well as the oncogenic versions of these genes and not in the control cells, transfected with the empty vector ( Figure  6 ). Thus, all the characteristics found in the induction of apoptosis by the Aplysia rho gene were also found in cells overexpressing the human Rho A, Rho C and Rac 1 proteins, as expected from the high degree of conservation of the Aplysia protein compared to the human Rho A, Rho B and Rho C proteins. These results indicate also that the mechanism for induction of apoptosis follows similar pathways for the Aplysia and the human Rho proteins, and that this mechanism involves the generation of increased levels of ceramides.
Apoptosis induced by Rho proteins is blocked by expression of the Bcl-2 protein
The proto-oncogene bcl-2 was isolated from the t(14;18) chromosomal breakpoint in a follicular Blymphoma (Tsujimoto et al., 1985) . It has been shown that expression of the Bcl-2 proteins inhibits apoptosis induced by a variety of stimuli (Harrington et al., 1994b) . We have previously reported that overexpression of the rho gene from Aplysia in NIH3T3 cells induces cell transformation and tumorigenicity in nude mice (Perona et al., 1993) . Analysis of the tumors generated by two of the rho-transformed cell lines generated, WT15 and WT16, had high rates of apoptotic ®gures in vivo (JimeÂ nez et al., 1995) . In order to investigate whether apoptosis induced by Rho proteins was sensitive to Bcl-2 expression, we introduced the bcl-2 gene under the control of a strong eucaryotic promoter into both the WT15 and WT16 cell lines and tested for the induction of apoptosis under conditions of serum deprivation. The generated cell lines were ®rst tested for Bcl-2 expression by Western-blot using a speci®c antibody (Figure 7a and b). Several clones showing either none or elevated levels of expression of the Bcl-2 product were chosen and the induction of apoptosis after serum withdrawal determined (Figure 7c and d) . Apoptosis in either of the parental cell lines, WT15 or WT16, was drastically inhibited by Bcl-2 expression as demonstrated by a complete correlation between levels of Bcl-2 expression and a lack of generation of the DNA ladder. Furthermore, the increase in the levels of ceramides after serum removal was not aected by expression of Bcl-2 (data not shown), an indication that Bcl-2 is downstream of ceramide production.
Tumors generated by cells overexpressing the Aplysia rho gene have a high apoptotic index (JimeÂ nez et al., 1995) . Since Bcl-2 expression blocks apoptosis in vitro, we also investigated the eect of Bcl-2 expression under in vivo conditions. To that end, several of the clones generated by expression of Bcl-2 in the rho-transformed cells were injected into nude mice, and tumors analysed for apoptotic ®gures as previously described (JimeÂ nez et al., 1995) . As expected, cells overexpressing the Bcl-2 protein alone were not tumorigenic, since no tumors developed after 6 months of injection, as with the parental NIH3T3 cells. In contrast, cells transformed by the Aplysia rho gene developed tumors of 1 cm in diameter after two weeks on injection. Equivalent tumors developed with a much faster rate when cells expressed both the rho and bcl-2 genes, in comparison to those expressing rho alone (Table  1) . Control WT15 cells had a mean value of 16 days to develop tumors of 1 cm in diameter. In contrast, the four WT15-derived clones analysed expressing the Bcl-2 protein, had a latency of 8 ± 9 days to develop tumors of a similar size, similar to that of ras-transformed cells. The histopathological analysis of paran blocks derived from each tumor indicated a reduction of prevalence of apoptotic ®gures from 7.7 in the control WT15 cells, to 1.5 ± 2.5 in the selected clones. This represents a reduction of 70 ± 80% (P50.0001) in the presence of apoptotic ®gures of these tumors. By contrast, when the prevalence of mitotic ®gures were analysed in the same tumors, no signi®cant dierences were found among all the samples analysed, indicating that Bcl-2 expression does not aect the proliferation rate, but only the apoptotic induction, under in vivo conditions. Consistent with this, the apoptosis/mitosis ratios were drastically reduced in all the tumors generated when the Bcl-2 protein was expressed (Table 1) .
Involvement of Rac 1 in the induction of apoptosis by TNFa in U937 cells
The observation that the ectopic expression of Rho proteins into NIH3T3 or K562 cells induces apoptosis in the absence of serum raises the question whether this eect is representative of a normal physiological process or whether it re¯ects inappropriate activation of endogenous signals ending in an artefactual and lethal con¯ict in growth signals. Thus, we investigated the role of Rho proteins in the regulation of apoptosis in response to cellular stress that triggers cell death. A 3 ± 4-fold increase in the total amounts of Rac 1 and Rho A proteins (Figure 8a ), determined by Western blot, were observed 24 h after TNFa treatment of myeloid leukemic U937 cells (50 ng/ml). In keeping with previous observations by numerous investigators, this treatment eciently induced apoptosis in U937 cells (Figure 8b ). This result suggests a correlation between transcriptional regulation of the levels of Rho proteins and the induction of apoptosis. To explore this possibility, we used the dominant negative mutants RhoA-Asn19 or Rac1-Asn17. Expression of these Rho proteins was achieved by transient transfection of the corresponding plasmids and then apoptosis induced by Figure 3 Induction of apoptosis by overexpression of the human Vav or Ost proteins in NIH3T3 cells. NIH3T3 cells were transfected with appropriate plasmids carrying the human vav oncogene and proto-oncogene and ost oncogene. (a) Pools of transfected cells were selected for G418 resistance, and equivalent amounts of total protein lysates were analysed by Western blot for the levels of expression of the Vav protein using a speci®c antibody (Santa Cruz Biotechnology). The Vav oncoprotein is a truncated form of the vav proto-oncogene product and therefore has a smaller size. (b) Photographs of colonies grown in soft agar from vav-and ost-transformed cells. Cells transformed by the ras oncogene were included as control, along with the indicated cell lines. (c) DNA fragmentation typical of apoptosis in cells transformed by the ost oncogene, the vav proto-oncogene and the vav oncogene in serum-deprived conditions. Dierent pools of NIH3T3 constitutively expressing these genes as well as the vector (pZIPneo) were seeded in DMEM supplemented with 10% New born calf serum (NCS) for 3 days and then the medium was substituted by DMEM without serum for 24 h. Cells were then analysed for DNA fragmentation in agarose gels and stained with ethidium bromide TNFa treatment. After 24 h of transfection, cells were treated with 50 ng/ml TNFa, and the induction of apoptosis determined 24 h later by the detection of the DNA ladder. As shown in Figure 8c , a drastic reduction in apoptosis, determined as the appearance of the DNA ladder, was observed speci®cally in the Rac 1-expressing cells, but not in the Rho A-expressing cells. Expression levels for both dominant negative mutants were similar (data not shown). Thus, although both Rho A and Rac 1 levels are increased after TNFa addition in U937 cells, Rac 1 but not Rho A is required for the induction of apoptosis triggered by
TNFa. These results demonstrate that the levels of diverse Rho proteins and in particular Rho A and Rac 1 are regulated in response to signals that trigger apoptosis in the human myeloid leukemia U937 cells and that Rac 1, but not Rho A is necessary for induction of apoptosis by TNFa.
Discussion
Rho proteins are very important signaling elements regulating many dierent cell functions. These proteins are involved in signal transduction pathways relevant to cell growth and transformation (Perona et al., 1993; Qiu et al., 1995; Khosravi-Far et al., 1995) . They are also cytoskeleton regulators inducing the formation of stress ®bres, membrane ruing and focal adhesion , lamelipodia and ®llopodia (Nobes and Hall, 1995; Kozma et al., 1995) , cell motility (Takaishi et al., 1993 (Takaishi et al., , 1994 smooth muscle contraction (Hirata et al., 1992) , cytokinesis (Kishi et al., 1993) vesicular transport in Golgi (Sugai et al., 1992) and platelet aggregation (Morii et al., 1992) . Regulation of cell cytoskeleton may be important to functions such as apoptosis (Rouslahti and Reed, 1995) and metastasis (Michiels et al., 1995; del Peso et al., 1997) , where cell adhesion may play a critical role. In fact, Tiaml, a protein that has been shown to have guanine exchange activity towards Rho proteins, was isolated as a gene involved in invasion (Habets et al., 1994) .
Previous studies from our group (Perona et al., 1993) and others (Koshravi-Far et al., 1995; Qiu et al., 1995) have demonstrated that rho and rac genes are oncogenic. The results presented in this study strongly support the function of Rho proteins also in the regulation of apoptosis. Here we demonstrate that the overexpression of the human Rho A, Rho C and Rac 1 proteins as well as oncogenic versions of these genes induce apoptosis in NIH3T3 cells under antiproliferative conditions such as serum withdrawal. We also demonstrate that the transformation of NIH3T3 cells by the human oncogenes vav and ost, two of the known guanine exchange factors speci®c for Rho proteins, exert the same eect. Induction of apoptosis by Rho is not restricted to a particular cell type since both the murine NIH3T3 ®broblasts and the human erythroleukemia K562 cells were sensitive. Finally, Rac 1, but not Rho A seems to be required for the induction of apoptosis by TNFa in U937 cells, strongly supporting the role of Rho proteins in apoptosis.
We have investigated the mechanism involved in this process. Apoptosis induced by Rho proteins is independent of p53, since overexpression of Rho C in K562 was also capable of eciently inducing apoptosis under conditions of serum deprivation, and it is well established that K562 are devoid of the oncosuppressor protein p53 (Prokocimer et al., 1986) . Furthermore, the induction of apoptosis by Rho proteins is sensitive to the expression of Bcl-2 protein, and this inhibitory eect was observed both under in vitro conditions, in cultured cells as well as under in vivo conditions in the Left (a, c, e) , phase contrast microscopy. Right (b, d, f),¯uorescence microscopy of the same ®elds shown in a, c, and e respectively. Analysis was performed in the parental K562 cells (a, b), the CP7 clone (c, d) and the transfected pool (e, f). Induction of apoptosis was determined 24 h after serum deprivation tumors generated when the rho-transformed cells were inoculated into nude mice. It is interesting to note that although the prevalence of mitotic ®gures of the tumors were very similar regardless of the expression of the Bcl-2 protein, a drastic reduction of 70 ± 80% in the prevalence of apoptotic ®gures was observed. Furthermore, tumors developed faster in those cells expressing both Bcl-2 and Rho proteins compared to the control, rho-transformed cells, and were very similar to those induced by the ras-transformed cells. These results are consistent with the known functions of the Bcl-2 protein as suppressor of apoptosis stimulating faster net tumor growth (Harrington et al., 1994b) .
Induction of apoptosis by overexpression of the human Rho A and Rho C proteins correlated with an increase in ceramide levels after serum removal. As discussed above, no detectable apoptosis was observed in the Rho-expressing cells in the presence of serum in NIH3T3 cells or K562 cells. These results suggest that Rho expression is not sucient to induce apoptosis.
However, addition of ceramides triggered apoptosis in Rho A, Rho C and Rac 1 overexpressing cells even in the presence of serum. These results indicate that the convergence of at least two independent signals is required for the induction of apoptosis in NIH3T3 cells, a concept that resembles the requirement for competence and progression factors for full mitogenic response (Aaronson, 1991) . While ceramides may be the progression factor for apoptosis in this system, we have not uncovered yet the identity of the competence factor for apoptosis in the Rho-expressing cells. However, there are already some observations that may lead to the identi®cation of this factor, such as those described below. 
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Figure 6 Induction of apoptosis by exogenous addition of synthetic ceramides. Analysis of DNA fragmentation was performed essentially as described in the legend to Figure 1 . Control, NIH3T3 cells and those overexpressing Rho A, Rac 1 and Rho C, as well as their oncogenic versions, RhoA-Leu63 (Rho A QL), Rac 1-Leu61 (Rac 1 QL) and RhoC-Val14 (Rho C V14), were incubated in DMEM supplemented with 10% NCS until they reached 70% con¯uence. The medium was then substituted with DMEM 10% NCS with C2 ceramide (100 mM) for 48 additional hours. DNA was extracted and resolved as indicated in Materials and methods. The experiment was repeated twice with similar results a Data shown as apoptotic and mitotic indexes are means of counts per ten high power ®elds.
b Apoptit Index for WT15 is signi®cantly greater (P<0.0001, Student's t test) than those for bcl-2-48, bcl-2-411, bcl-2-412 and bcl-2-415.
c Mitotic Index for WT15 shows no signi®cant dierences from all the bcl-2/rho expressing cell lines Strong support for a dual role of Rho proteins in the regulation of cell growth and apoptosis comes from the evidence that Rho proteins induce activation of the pathway leading to the JNK/SAPK cascade in several cell systems (Coso et al., 1995; Minden et al., 1995; Teramoto et al., 1996 Perona et al., 1997) as well as the nuclear factor kB (NF-kB) (Perona et al., 1997) . These two pathways are frequently activated as a consequence of stress induction by agents such as UV light exposure or treatment with genotoxic drugs and cytokines that are associated with the induction of programmed cell death. Recent studies indicated that JNK (Verheij et al., 1996; Liu et al., 1996; Xia et al., 1995) and NF-kB (Van Antwerp et al., 1996; Wang et al., 1996; Beauparlant et al., 1994) may indeed have dual eects on positive and negative regulation of cell proliferation and apoptosis, depending on the cell system, further supporting the dual role of Rho proteins in the regulation of these cell responses. Whether JNK/SAPK or NF-kB cooperate with ceramides for the induction of apoptosis in the Rhoexpressing cells still remains to be explored. In addition, there are already several eectors identi®ed for Rho proteins such as PAK (Manser et al., 1994; Martin et al., 1995) , rhophilin and PKN (Amano et al., 1996; Watanabe et al., 1996) and others, that may also be candidates to be involved in this function ascribed to Rho proteins.
The eects on apoptosis that we have shown in this study are unlikely to be a consequence of unspeci®c mis-sorting of the Rho proteins due to overexpression. Two lines of evidence are provided to support this. First, transformation by two known guanine exchange factors for Rho proteins, vav and ost, have the same eect. Second, a two-hit signal is absolutely required to induce apoptosis: overexpression of the Rho proteins itself is not sucient to trigger cell death since serum withdrawal should be also carried out. Furthermore, ceramides addition can induce apoptosis speci®cally in the Rho-expressing cells, even in the presence of serum. Finally, a more physiological approach has also been used. We have demonstrated that Rho A and Rac 1 expression are increased after TNFa treatment in U937 cells. Furthermore, a dominant negative mutant of Rac 1 interferes with the induction of apoptosis by TNFa in this cellular system, while the corresponding mutant of Rho A has no eect under similar conditions. Whether Rho A and Rac 1 play dierent roles in TNFa-dependent signaling is still unknown and deserve further attention. However, our results support a dierential role for each protein, since both proteins are induced after TNFa treatment. In keeping with these results, it has been shown by Fritz et al., (1995) that the levels of expression of Rho B are increased upon genotoxic stress, such as UV light and the addition of cisplatin and that apoptosis induced by Fas depends upon Ras and Rac-dependent signaling 10.16 Figure 7 Bcl-2 expression inhibits apoptosis in cells transformed by the Aplysia rho gene. (a, c). Aplysia Rho clones, WT15 and WT16 were cotransfected with a plasmid carrying the bcl-2 gene or with the pSV2-hygro plasmid alone. After selection with hygromicin, several clones were selected, and equivalent amounts of total protein lysates were analysed by Western blot for the levels of expression of the Bcl2 protein using a speci®c antibody. (b, d) DNA fragmentation of the clones selected in the absence of serum. Those clones that overexpressed Bcl2 in the WT15 and WT16 clones (48.15, 412.15, 415.15, 10.16, 11.16, 42.16, 43.16 and 48.16) showed no DNA fragmentation. In contrast, the parental cells (WT15 and WT16) and those clones with no detectable expression of showed DNA fragmentation Apoptosis induced by activation of rho signaling P Esteve et al (Gulbins et al., 1996) . Also it has been shown that the mRNA expression for Rho A is increased in breast cancer cell lines growth-arrested with lovastatin (Moscow et al., 1994) . In contrast with these results, it has been proposed that Rho A inactivation promotes apoptosis in a T cell lymphoma line (Moorman et al., 1996) . In this study, high levels of expression of the Clostridium botulinium exoenzyme C3 are achieved by infection with a Sindbis virus vector. C3 is known to ADP-ribosylate and inactivate Rho A. However, we have observed that when C3 is transiently expressed in NIH3T3 and COS-7 cells, it is highly toxic and in fact it does activate both the JNK/SAPK and NF-kB pathways itself (data not shown). Thus, high levels of expression of C3 may not be an appropriate approach to investigate for the function of Rho proteins in mammalian cells.
From the results presented in this study, it can be proposed that dierent members of the family of human Rho GTPases mediate in the regulation of apoptosis in response to stress signals such as absence of serum, cytokines or genotoxic treatments. Apoptosis induced by Rho proteins is independent of p53, but sensitive to Bcl-2 expression and correlate with the generation of ceramides. Some of the pathways that are activated by Rho proteins such as the JNK/SAPK kinase or the NF-kB transcription factor may complement the increase in ceramides for a complete apoptotic response. Further research would be required for a full identi®cation of the pathways involved in this important function mediated by Rho proteins.
Materials and methods
Expression plasmids
The plasmids pCEV29, pCEV29-Rac1, pCEV29-RhoA, pCEV29-RhoA-Leu63, pCEV29-Rac1-Leu61 contain the indicated full-length cDNAs under the control of LTR promoter of MMLV. To generate clones constitutively expressing the rho C gene we utilized the expression plasmid pLNCX. This plasmid contains the human rho C full-length cDNA under transcriptional control of CMV promoter and the neomycin resistance gene. The human bcl-2 gene, a generous gift from SJ Korsmeyer, was under the control of the SFFV.neo expression plasmid.
Cell transfections
NIH3T3 cells were maintained in Dulbecco's Modi®ed Eagle medium (GIBCO) supplemented with 10% new born calf serum (GIBCO) under standard conditions of temperature (378C), humidity (95%) and carbon dioxide (5%). Generation of cell lines overexpressing the indicated genes was carried out by transfection of NIH3T3 cells by the calcium phosphate method. The day before, cells were seeded at a density of 3610 5 cells per 100 mm dishes. Transfections were carried out using 1 mg of the indicated DNA and 20 mg of DNA carrier. After 16 h of incubation, cells were washed with saline phosphate buer and fed with DMEM supplemented with 10% NCS. One day later, G418 (GIBCO) was added to the medium and individual resistant colonies were pooled or isolated with cloning cylinders. K562 were grown in RPMI medium supplemented with 10% fetal calf serum and glutamin. Cells were transfected by electroporation and after 2 weeks of selection with G418 (200 mg/ml), cells were diluted to isolate clones. Clones were expanded and maintained in RPMI medium under standard conditions of humidity and CO 2 atmosphere.
Transient transfections
U937 cells were mantained in RPMI medium supplemented with 10% fetal calf serum (GIBCO) under standard conditions. 30610 6 cells were transfected by electroporation and resuspended in 30 ml of RPMI. After 24 h cells were centrifuged and resuspended in 3 ml of RPMI and 3 ml of Histopaque-1077 (Sigma) added. The mix was then centrifuged at 400 g for 30 min at room temperature. After centrifugation the upper layer was aspirated and discarded and the opaque interfase was transferred into a fresh tube and washed twice with RPMI. The equivalent number of cells of each cell line were treated with 50 ng/ ml of Tumor Necrosis Factor (TNFa) (Upstate) during 24 h. After that the cells were collected and treated as described above for the NIH3T3 cells to visualize DNA fragmentation by the ethidium bromide staining procedure.
Western blot analysis of protein expression
Cells were grown under standard conditions until reaching 80% of con¯uence or serum-starved until needed in the experiments. They were then washed twice with ice cold TD buer (137 mM NaCl, 5 mM KCl, 1 mM Na 2 HPO 4 , 20 mM Tris pH 7,4) and lysed in 300 ml of ice cold lysis buer (50 mM Tris pH 7.4, 0.25% NP40, 0.25% SDS, 150 mM NaCl, 15 mM b-glycerophosphate, 10 mM NaPPi, 50 mM NaF, 10 mg/ml aprotinin, 1 mM PMSF). Nuclei and detergent insoluble material was removed by centrifugation at 13 000 r.p.m. for 15 min. The resulting supernatants were analysed for stimation of total cell protein (Bio-Rad) and equal amounts of cell lysates (15 mg) were boiled at 958C for 3 min in SDS ± PAGE sample buer. For Western blot analysis, proteins were electroforesed onto 12% SDS ± PAGE gels. Resolved proteins were transferred to nitrocellulose and blots were blocked in 4% non fat dried milk in TTBS (0.05% Tween 20) and were incubated with the appropiate antibodies at 1/1000 dilutions and developed by ECL (Amersham). Rho A monoclonal (SC-418) and Rac 1 polyclonal (SC-217) antibodies were from Santa Cruz. The anti-Rho A antibody was able to recognize the Rho C protein also.
Northern blot of mRNA expression
Cells were grown under standard conditions until reaching 80% of con¯uence. They were then washed twice with ice cold TD buer (137 mM NaCl, 5 mM KCl, 1 mM Na 2 HPO 4 , 20 mM Tris pH 7,4). Total RNA was isolated with RNA isolation kit according to the manufacturer's instructions (Ultraspec TM -II, Biotecx). Ten mg of total RNA were denatured by treatment with formaldehyde and formamide and electrophoresed through 1% agarose/formaldehyde gels. RNAs were transferred by capillary action onto nylon membranes and ®xed to the membrane by UV irradiation. The quality and the amounts of RNA in each lane were controled by methylene blue staining. The rho C probe was labeled with g-32 P-dCTP (3000 Ci mmol 71 ) by random priming (Ready to go TM DNA labeling KIT, Pharmacia) using 50 ng of rho C cDNA that was liberated from the plasmid pLNCX-Rho C by digestion with EcoRI. The membranes were hybridized for 14 h at 658C in 16SSC without formamide, washed at 658C in 0.16SSC and exposed to X-ray ®lm.
Determination of DNA fragmentation by ethidium bromide staining
Equivalent number of cells (5610 5 ) of each cell line were seeded into 10 cm dishes and grown in DMEM supplemented with 10% NCS for 3 days before treatment. After the indicated incubation periods, the total cell population (adherent and detached cells) were collected and lysed in 1 ml of 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 25 mM EDTA, 0.5% SDS. Lysates were incubated for 4 h at 508C with 0.2 mg/ml proteinase K. After extraction with an equal volume of phenol : chloroform : isoamyl alcohol (25 : 24 : 1 v : v : v), followed by re-extraction with chloroform : isoamyl alcohol (24 : 1 v : v), DNA was precipitated by addition of 0.1 volume of 3 M sodium acetate, pH 5.3, and one volume of isopropanol at 7708C for at least 1 h Precipitated DNA was collected by centrifugation at 14 000 g for 30 min at 48C, washed with ice-cold 80% ethanol and air-dried. DNA was then resuspended in 10 mM Tris HCl pH 7.5, 1 mM EDTA (TE buer) and treated with 0.5 mg/ml RNAase at 378C. DNA samples were fractionated by electrophoresis in a 1.0% TBEagarose gel at 70 V and visualized by ethidium bromide staining.
Cell death assay in K562 cells
To ensure that all clones were analysed in exponential growth phase, cells were seeded at 0.2610 6 cells/ml the day before analysis. The next day an equivalent number of cells of each cell line were seeded into F75 bottles without serum. Cells were analysed by staining with Trypan Blue (1%) and counting the dead cells in a hemocitometer. Although cells undergoing apoptosis in vitro exclude vital dyes, such as Trypan Blue, in the early stages of apoptosis, as they enter phase 3 apoptosis, the dying cells undergò secondary necrosis' and take up Trypan Blue, allowing assessment of cell survival. Where indicated K562 cells were analysed by the Annexin V Apoptosis Detection Kit (Genzyme) according to the manufacturer's protocol. Cells were observed by¯uorescence microscopy.
Flow cytometry analysis
Cells were processed according as previously described (JimeÂ nez et al., 1995) . Brie¯y, after treatment, adherent and non-adherent cells were pooled and ®xed in 1 ml of 70% cold ethanol in cold PBS for 15 min at 48C. Then cells were washed in cold PBS and cells were centrifuged at 1500 r.p.m. and resuspended in 1 ml of PBS. Cells were stained with propidium iodide (10 mg/ml) and incubated with 20 mg/ml of RNase for 30 min. Samples were analysed using a Facsan Flow Citometer. Representative histograms showing total DNA content as FL2-A (IP) vs cell number (counts) are shown.
Analysis of ceramide production
Con¯uent cultures were labeled in medium containing indicated amounts of serum, supplemented with 1 mCi ml 71 of 14 C-Serine for 24 h. The reactions were terminated by placing the dishes on ice and removing the medium. Cells were scrapped from the dish in 1 ml of 0.1 N HCl, lipids extracted with chloroform/methanol/ concentrated HCl (100 : 200 : 1), and phases were separated exactly as described by Olivera et al. (1992) . The chloroform extracts were saponi®ed in 0.1 M methalonic KOH at 378C for 1 h to eliminate the ester-containing glycerolipids. Sphingomyelin and ceramide were separated by sequential onedimensional TLC in chloroform/benzene/ ethanol (80 : 40 : 75) followed by chloroform, methanol, 28% ammonium hidroxide (65 : 25 : 5). The corresponding standards were also run. Lipids were located by autoradiography and the radioactivity quanti®ed by liquid scintillation counting of the corresponding silica gel areas.
